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Herpes simplex virus type 1 (HSV-1) infection of the nervous system may lead to brain 
damage, including neurodegeneration. However, lack of suitable experimental models hinders 
understanding molecular mechanisms and cell-type-specific responses triggered by HSV-1. 
Here, we infected human brain organoids with HSV-1. Known features of HSV-1 infection 
such as alteration of neuronal electrophysiology and induction of antisense transcription were 
confirmed. Full-length mRNA-sequencing revealed aberrant 3’ end formation and poly(A)-tail 
lengthening. Single-cell RNA-seq and spatial transcriptomics uncovered changes in the cellular 
composition of the infected organoids caused by viral replication and dysregulation of 
molecular pathways in cell-type specific manner. Furthermore, hallmarks of early 
neurodegeneration were observed, namely extracellular matrix disruption, STMN2 and 
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TARDBP/TDP43 downregulation, and upregulation of the AD-related non-coding RNA 
BC200/BCYRN1. These hallmarks were weaker/absent when infecting with a mutant HSV-1 
control. Together, our data indicate that brain organoids serve as a powerful model to study 
mechanisms of HSV-1-driven neurodegeneration.  
 
Introduction 
Herpes simplex virus type 1 (HSV-1) is a common human-specific pathogen affecting a large 
part of the population worldwide (1). After primary replication in epithelial cells, HSV-1 
travels along axons innervating the affected regions to the trigeminal ganglia to establish a 
latent state of infection. The latent HSV-1 genome persists in episomal form within the nucleus, 
and HSV-1 DNA is chromatinized with heterochromatic histone marks. In this state, only a 
small subset of viral genes is transcribed, including the latency-associated transcripts (LATs) 
(2,3). Investigations of post-mortem human tissue have provided evidence of LAT 
transcription/virus not only in trigeminal ganglia (4) but also in the brain at large (3). Latent 
viral infections can persist over years with very limited transcription. However, stimuli such as 
stress signals and weakened immunity can cause the reactivation of HSV-1 from sensory 
neurons at any time (3). 
Two different forms of infection-related diseases in the brain have been observed. First, lytic 
infection, either by reactivation from latency or primary infection (5) in the central nervous 
system (CNS) can cause herpes simplex encephalitis (HSE), with an incidence of 1 in 10,000 
infected individuals (6). HSV-1 infection in CNS is the most common cause of viral 
encephalitis (7). Second, HSV-1 is gaining increasing attention as a potentially causative agent 
in the pathogenesis of sporadic Alzheimer’s disease (AD) (8–12). Already decades ago, it was 
observed that HSE often occurred in the brain regions that are most frequently affected by AD 
(12). Furthermore, viral DNA was detected at high levels in amyloid plaques from sporadic 
AD post-mortem brain samples (13,14). More recently, a population study reported that HSV-1 
infection and seropositivity led to a significant risk of later development of AD (8,9,11,13,14). 
The current understanding of the mechanisms of HSV-1 infection, latency and reactivation in 
the CNS are based either on animal models or on in vitro differentiated neurons. These models 
cannot fully account for human-virus interaction specificity or cellular and functional diversity 
in neural tissues, respectively (15–18). Therefore, physiologically relevant human 
experimental models are needed to improve our understanding of the consequences of lytic and 
latent HSV-1 infection in the human CNS.   
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In recent years, human stem cell-derived brain organoids have emerged as models that capture 
several important aspects of human brain development and physiology (19–21). We 
hypothesized that brain organoids may offer an opportunity to molecularly study fundamental 
aspects of HSV-1 - brain tissue interaction. Indeed, recent data of acute and latent infections 
argue for the suitability of human induced pluripotent stem cell (hiPSC)-based neuronal models 
and brain organoids to study HSV-1 impact on neural cells (10,15,22). However, the CNS 
consists of many cell types, and it is unknown how efficiently the virus replicates in them, and 
whether these cell types respond differently to the infection. Interestingly, several features of 
AD, including amyloid plaque-like formation, gliosis and neuroinflammation were reported in 
3D in vitro bioengineered neuronal culture (10). Nevertheless, the primary molecular 
mechanisms of HSV-1-driven neurodegeneration remain elusive but might be crucial for the 
potential identification of new drug targets.   
In this study, we explored human cerebral organoids as a model system to capture cell-type 
specific molecular mechanisms employed by the virus and human brain cells to interact upon 
infection. Specifically, we used physiological and molecular bulk assays including full-length 
transcript sequencing (23) as well as single-cell RNA-sequencing and spatial transcriptomics 
to capture the functional and molecular consequences of HSV-1 infection on human brain cells 
in a physiologically relevant and complex cellular context and at single-cell resolution. 
Functionally, we were able to demonstrate with high-density multi-electrode measurements 
and, independently, real-time calcium imaging that HSV-1 infection massively damages 
neuronal activity in the organoids. Molecularly, we observed that HSV-1 heavily affected the 
cerebral organoid transcriptome at multiple levels, by activating antisense transcription, 
strongly modulating mRNA 3’ end formation and alternative polyadenylation, but also 
specifically dysregulating genes with synaptic, extracellular matrix and DNA-binding function. 
Furthermore, viral infection changed the cellular composition of organoids and triggered or 
repressed numerous cell-type specific molecular pathways, several of them being clearly 
related to neuroinflammation and early neurodegeneration. Specifically, we detected 
downregulation of neuronal growth associated protein stathmin-2 (STMN2) and TAR DNA-
binding protein 43 (TDP43/TARDBP) and upregulation of the non-coding RNA 
BC200/BCYRN1, which was shown to be dysregulated in AD patients’ brains (24). Expression 
changes of these genes are associated with AD pathogenesis (24–26). 
 
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is 
The copyright holder for this preprintthis version posted March 7, 2021. ; https://doi.org/10.1101/2021.03.05.434122doi: bioRxiv preprint 
4 
Results 
Modeling HSV-1 infection using human cerebral organoids 
We generated cerebral brain organoids from two different iPSC lines according to the 
optimized Lancaster et al. protocol (19,27,28) (Figure 1A). These organoids had 
predominantly dorsal forebrain region specification and contained multiple ventricle-like 
structures formed by SOX2/PAX6-positive neural progenitors surrounded by EOMES-positive 
intermediate progenitors and an early cortical-like structure formed by MAP2/TUJ1/LHX2-
positive neurons (60 days old organoids, Figure 1A; 30 and 60 days old organoids, Figure 
S1A). At day 60, glial fibrillary acidic protein (GFAP) positive astrocytes started to emerge 
(Figure S1A). Also, the outer subventricular zone and neuronal layers expanded, which was 
reflected by expression of outer radial glia marker - HOPX and different neuronal markers such 
as TBR1/TBR1 (deeper layer cortical neurons), CTIP2/CITP2 and Reelin/RELN of Cajal-
Retzius neurons (Figure 1B and S1A, B). These data indicate that cerebral organoids generate 
major cell types typical for early brain development. Furthermore, gene expression comparison 
between organoids derived from the two different iPSC lines showed an overall similar 
developmental signature, with the exception that iPSC line-1 additionally showed induction of 
the mesodermal lineage (VCAN, LUM), whereas iPSC line-2 showed more homogenous 
development towards dorsal forebrain (Figure S1C).  
To assess cell type composition of developing organoids, we performed single-cell RNA-seq 
analyses of 30 and 60 days old organoids (Figure 1C and S1D, E). We combined highly 
reproducible single-cell transcriptomes from two biological replicates (60 days shown in 
Figure S1D) of each time point and identified six and fourteen transcriptionally distinct 
clusters in 30- and 60-day-old organoids, respectively (Figure 1C and S1E). Additionally, we 
performed differential expression analysis to select genes which defined each cluster (examples 
Figure S1F). In this way, we were able to identify multiple types of progenitors and neurons 
in 30 days old organoids and additionally astroglia in 60 days old organoids (Figure 1C and 
S1E). 
Furthermore, we used the 10x Genomics Visium platform to define spatial mRNA expression 
in 60 days old organoids derived from both iPSC lines. We checked the distribution and 
colocalization of different cell-type specific markers using the Loupe Browser (10x Genomics). 
Neuron-specific transcripts such as the pan-neuronal marker DCX and synaptic marker SYN1, 
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colocalized in several regions around the organoid periphery, while a marker of proliferating 
progenitors (MKI67) localized in regions compatible with ventricle-like structures. Also, TTR, 
a marker of choroid plexus, showed localized expression (Figure 1D for iPSC line-1 and S1G 
for iPSC line-2). These results correlate well with the immunohistochemistry of developing 
cerebral organoids (19).  
Next, we infected 60 days old brain organoids with HSV-1-GFP and performed a variety of 
analyses shown in Figure S1H to investigate molecular, cellular and physiological changes. 
First, however, we assessed the infection efficiency by spatial transcriptomic analysis of GFP 
mRNA expression and by immunohistochemistry for GFP protein (Figure 1E and S1I). We 
detected viral RNA throughout the entire organoid, reaching even the deepest inner layers 
already at 3 dpi (Figure 1E), demonstrating the viral spreading from exterior to interior. On 
the protein level as measured via the GFP signal, we observed efficient spreading of the virus 
into the organoid outer layers at 3 dpi and expanding into the deeper inner layers at 6 dpi 
(Figure S1H). As expected, the necrotic core of the organoids did not show a signal for mRNA 
or protein GFP expression (Figure 1E and S1I). 
In order to assess transcriptome changes of infected organoids, we performed a systematic 
analysis of bulk RNA expression, single-cell RNA-seq analysis and 10x Genomics Visium for 
all time points (3 and 6 dpi) and experimental conditions. Furthermore, we assessed the 
changes in alternative polyadenylation and poly(A) tail length by full-length mRNA 
sequencing and spontaneous neuronal activity by extracellular high-density multielectrode 
array (MEA) recordings and calcium imaging after HSV-1 infection. Immunostainings and 
real-time quantitative PCRs served as validation tools (Figure S1H). 
 
Molecular analyses of HSV-1 infected organoids reflect known facts about HSV-1 biology  
To identify genes related to virus response, we profiled the transcriptomes of 60 days old 
uninfected, and infected (3 dpi and 6 dpi) organoids from two iPSC lines using bulk RNA-seq. 
Because a large fraction of sequencing reads from the infected samples aligned to the HSV-1 
genome (up to 70%), we discarded these reads when analyzing cell types by clustering, since 
viral gene expression would otherwise dominate the analyses. In the principal component 
analysis, the first component reflected the genetic background and a slightly different 
developmental pattern of the two iPSC lines (Figure S2A). The second component indicated 
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strong deregulation of gene expression as a consequence of HSV-1 infection. Differential gene 
expression analysis was designed to account for the differences between genetic backgrounds 
(principal component (PC)1), and measure the consistent effects of infection (PC2) on gene 
expression (see Methods). 
This analysis of pooled samples from two iPSC lines showed that the infection led to 
systematically and statistically significant (p-value <0.05, log2 fold change cutoff 1) increased 
or decreased expression of 274 and 230 genes, respectively (Figure S2B). Downregulated 
genes were enriched for genes involved in synaptic function, extracellular matrix organization 
and development (Figure S2C and D), while upregulated genes were significantly enriched for 
DNA-binding transcription factor activity (adjusted p-value < 0.05) (Figure S2E). These gene 
expression changes were consistent between two iPSC lines, as shown in Figure S2D and E. 
 
It has been previously reported that lytic HSV-1 neuronal infection causes synaptic 
dysfunction, associated with disassembly of key structural components of dendritic spines and 
upregulation of activity-regulated cytoskeleton-associated protein (ARC) mRNA and protein 
expression (29,30). In our system, we observed massive downregulation of major pre- and 
postsynaptic components, including synaptic vesicle genes (SV2A, SV2B, SYP, VAMP2) and 
genes that function in calcium signaling (SYT13, CAMK2A, CAMK2B, CALB2) (Figure 2A). 
On the other hand, at the early stages of the infection, we could observe the previously reported 
upregulation of neuronal activity-related genes such as pentraxin NPTX2, EGR2 or ARC (24). 
The expression changes for synapsin-1 (SYN1), postsynaptic density scaffolding protein 1 
(HOMER1) and ARC were also shown for the proteins using immunostaining (Figure 2B) and 
western blot analysis (Figure 2C).  
On the transcriptome level, we could recapitulate a widespread induction of antisense 
transcription, which has been previously reported in human primary fibroblasts (31). For the 
detection of antisense transcripts in 60 days old organoids, we defined all transcribed regions 
outside of annotated genes using the running sum algorithm (31) and filtered out potential 
transcriptional readthroughs. In total, we defined 5279 antisense transcripts. Detected antisense 
transcripts showed strong and statistically significant upregulation upon HSV-1 infection at 
both observed timepoints (Figure 2D). Selected examples of antisense transcripts are shown 
in Figure 2E. 
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HSV-1 infection of brain organoids causes decreased synaptic firing rates and loss of 
coordinated neuronal activity  
To validate that the observed changes in synaptic gene expression had functional consequences, 
we performed functional analyses using two independent approaches: high-density 
multielectrode array recordings and real-time calcium imaging (32–34). In the first approach, 
60 days old organoids were placed on a 64-microelectrode array, which measures the voltage 
change from the large number of neurons present in the organoid tissue over time. Twenty 
hours after adding HSV-1 to the medium, the organoids showed a drastic decrease in the 
number of spikes compared to uninfected organoids, which maintained or even increased their 
spiking activity over time. No activity was detectable in the infected organoids after 40 h 
(Figure 2F and S2F). Brightfield microscopic images taken 48 h after infection showed that 
infected organoids also lacked outgrowing neurons, typically observed in uninfected organoids. 
(Figure S2G).  
In the second approach to study the impact of HSV-1 on neuronal activity of infected organoids, 
we used calcium imaging (Figure 2G, H and S2H, I). To assess intracellular calcium dynamics 
of spontaneous action potentials in both uninfected and infected organoids, we performed 
CalBryte590 AM-based calcium imaging using spinning disk confocal microscopy. After 
plating the organoids, neurons (TUJ1-positive cells), showed active migration and neurite 
extension towards the glass dish bottom (Figure S2H). Calcium imaging analysis indicated a 
high abundance of spontaneously active neurons in all organoids (day 0). Next, we tracked 
changes in spontaneous activity after 24 and 48 hours post infection (hpi) with the HSV-1. 
Uninfected organoids reveal a high number of active neurites at 48 hpi present (Figure 2G and 
Movie S1), which show coordinated activity (Figure 2H). In contrast, in HSV-1 infected 
organoids, the robust initial spontaneous calcium activity decreased after 24 h and was almost 
completely abolished after 48 h in infected organoids (Figure 2G and H and Movie S2). After 
48 h, the number of neurites was clearly reduced (Figure S2H) and the remaining neurites were 
silent or showed limited and uncoordinated activity (Figure 2I).  
HSV-1 infection causes global changes in poly(A) tail length and increased usage of distal 
polyadenylation sites  
Previous studies reported that alternative polyadenylation may play an important role in 
antiviral response for viruses such as vesicular stomatitis virus (35) and that herpes infection 
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can affect mRNA 3’ end formation by inducing premature polyadenylation (36) and 
readthrough transcription (37). Thus, to analyze the impact of herpes infection on alternative 
polyadenylation and, possibly, on poly(A) tails, we applied our recently developed full-length 
mRNA and poly(A) sequencing method (FLAM-seq, (23)) on three biological replicates of 
uninfected and HSV-1-infected 60-day-old organoids. 
FLAM-seq allows to (a) exactly annotate mRNA 3’ ends and (b) measure the poly(A) tail 
length of mRNAs. Read counts for cellular and viral genes had high correlation among 
replicates (Figure S3A). All tail length measurements and 3’ end annotations are reported in 
Tables S1 and S2. We observed that viral transcripts had poly(A) tails with a similar length 
distribution of cellular transcripts (Figure S3B), suggesting similar kinetics of tail synthesis 
and deadenylation. However, these distributions are mildly but significantly longer (median of 
158 nt taking in to account the GFP transgene, 139 nt without, compared to a median of 122 nt 
in uninfected organoids, p-value = 2.2E-16, distributions shown in Figure S3C). Also, the 
median tail lengths of cellular transcripts increased significantly upon infection (from a median 
of 122 nt to 135 nt, p-value = 2.2E-16). While the overall effect of infection was to increase 
tail lengths of cellular mRNAs, we note that 116 mRNAs had a significantly shorter tail 
(threshold of 25 nt, p-value < 0.05, Figure 3A and S3D). Interestingly, genes with shorter tails 
were significantly enriched in functional categories directly linked to viral infection (“positive 
regulation of viral transcription" and "regulation of viral transcription"), while mRNAs with 
longer tails were not enriched in specific functional categories. Since mRNAs that are highly 
translated tend to have short poly(A) tails, we hypothesize that tail lengthening might be linked 
to reduced translation of cellular mRNAs, while tail shortening of transcripts that are important 
for viral replication might reflect higher engagement in translation. We conclude that HSV-1 
infection causes a global deregulation of poly(A) tail lengths in cellular transcripts, possibly 
reflecting their different transcriptional and translational status.  
To study possible changes in polyadenylation site usage, we annotated transcription 
termination sites (TTSs) supported by at least two reads and labeled 3’ end isoforms for each 
gene with an “isoform index”, equal to 1 for the most proximal isoform and increasing distally. 
For several mRNAs, we observed a striking difference in usage of distal TTS in infected 
organoids, as shown for calmodulin 1 (CALM1) (Figure 3B).  
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The decrease of the usage of the first, proximal isoform and an opposite increase in the usage 
of all downstream isoforms were global and significant in the infected organoids (p-value = 
0.0098, Figure 3C and S3E), indicating a global shift in alternative polyadenylation upon 
HSV-1 infection. Since it has been observed that HSV-1 infection induces readthrough 
transcription in cellular genes, we asked whether the observed shift in TTS usage could be 
caused by failure in cleavage and polyadenylation, which could in turn increase the probability 
of downstream polyadenylation signal (PAS) usage. We therefore stratified the sequenced 
isoforms by published data (38) on HSV-1-induced readthrough transcription and observed that 
genes with high readthrough experience a slightly larger shift from proximal to all distal 
isoforms usage upon infection than genes with low readthrough, although this difference was 
not significant (p-value = 0.2548, Figure 3B and S3E). We therefore conclude that viral 
infection induces a global shift of 3’ end isoform usage from proximal to distal termination 
sites. Whether the observed shift is linked to transcriptional read-through or to alternative, 
unknown mechanisms warrants further investigation. 
  
Infection changes the cell-type composition of organoids  
Using droplet-based single-cell RNA-sequencing (39), we performed single-cell transcriptome 
profiling of 60-day-old organoids at 3 and 6 dpi, capturing both host mRNA and viral 
transcripts. Since the RNA levels at 6 dpi were very low, likely due to extensive host cell 
shutoff (40), we focused on the 3 dpi time point in further analyses. An overview of the dataset 
(Figure S4A), with the number of characterized cells for each sample, distribution of unique 
molecular identifiers (UMIs), i.e., the number of individually detected mRNA molecules per 
cell, the number of detected genes and the mitochondrial mRNA counts are provided (Figure 
S4B). To normalize and scale the gene expression values to account for differences in 
sequencing depth as well as align cells with similar transcriptome profiles across conditions, 
we used the scTransform method (41). 
By matching the transcriptomes of the individual cells to known marker genes, we defined 14 
cell types in both uninfected and infected organoids, including progenitor cells, astroglia, 
intermediate progenitor cells, mesenchymal cells, terminally differentiated neurons, and low 
RNA/highly infected cells (Figure 4A, B and S4C, D). Within the infected organoids, the latter 
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correspond to highly infected cells or cells with advanced HSV-1 infection stage (Figure 4A, 
B).  
Cell-type proportion changed significantly for several cell types, including proliferating cells, 
early neurons, neuroepithelial cells, neurons, and progenitor cells (p-value < 0.001, Figure 
4C). For the majority of the cell types, a significant decrease in cell number was observed after 
infection, only neuroepithelial cells and low RNA/highly infected cells showed a significant 
increase in relative cell number after viral infection (Figure 4C). Notably, a prominent 
decrease in the number of mitotic cells in the ventricular zone and in the whole organoid were 
observed in 3 dpi organoids generated from both iPSC lines (Figure 4D for iPSC line-1 and 
Figure S4E for iPSC line-2). Overall, these findings demonstrate that HSV-1 infection resulted 
in a decrease in the number of proliferating progenitors as well as more differentiated cell types. 
On the other hand, the infection increased the number of low RNA/highly infected cells. 
Interestingly, these cells are not only characterized by high viral transcript load but also 
qualitatively by expression of different types of viral genes, suggesting a more advanced 
infection stage (Figure S4G). 
  
Cell-type specific levels of viral replication  
Next, we asked to what extent the different cell types within the organoids would show distinct 
susceptibilities to infection. Although at 3 dpi, almost all cells contained viral RNA (Figure 
1E, S4H, I), the distribution of the viral load (percentage of viral transcripts/UMIs per cell) 
showed clear differences between cell types.  Retinal ganglia, progenitors, and low RNA/highly 
infected cells had the highest amount of viral RNA, with a median of up to 10-fold more than 
other cell types (Figure 4E). A previous single-cell RNA-seq analysis of a HSV-1 infected cell 
line (fibroblasts) showed that some host cell genes are induced by the infection and that this 
induction correlates with accumulating viral RNA per cell (42). We counted the intronic reads 
(quantifying transcriptional induction) for three of these genes, namely BCL2L11, RASD1 and 
RRAD. Among the cell types, which showed the strongest increase of these intron counts upon 
infection, were again the progenitor cells (Figure S4G). Thus, these data argue that not only 
the viral load is highest in this cell type but also the impact on host genes.  
Given the observed cell-type specific viral RNA load, we asked if not only viral load but also 
known, temporally ordered viral gene expression programs would be cell-type specific. To 
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investigate the course of the viral gene expression cascade in the different cell types, we ordered 
cells according to the amount of GFP mRNA, which serves as a proxy for viral replication, and 
grouped them into bins of 20 cells. For each bin, we calculated the relative expression values 
of the immediate early viral gene US1, and the late genes UL51 and LAT. We then compared 
the values for intermediate progenitors, mesenchymal cells and neurons with the low 
RNA/highly infected cell group (Figure 4E). The kinetic class of the genes shown here is 
reflected by the shape of the curve, with UL51 and particularly LAT starting to accumulate at 
higher amounts of GFP mRNA compared to US1, which steadily accumulates with increasing 
replication. 
All genes, and particularly LAT, reached highest counts in the low RNA/highly infected cells, 
which suggests that the late stage of the viral gene expression cascade is only reached therein. 
However, the accumulation of the US1 and UL51 depended on the amounts of GFP, and thus 
the temporal development of the gene expression cascade, was largely overlapping in 
intermediate progenitors, mesenchymal cells and neurons. 
Altogether, our data indicate that the different cell types show variable susceptibilities to viral 
infection.  
 
In advanced stages of HSV-1 infection, cells cannot be mapped to known cell types 
Within infected organoids, we identified a large population of cells that clustered together with 
'low_RNA' cells from control organoids. In uninfected organoids, we termed these cells 
'low_RNA' by virtue of the low number of RNA molecules captured per cell (Figure S4I) and 
the absence of shared marker genes, which hindered their assignment to a defined cell type. 
Interestingly, in 3 dpi organoids, cells co-clustering with 'low_RNA' ones, were in addition 
characterized by high expression levels of viral genes (Figure S4F). We considered these cells 
to have lost a recognizable cell identity as a consequence of advanced viral infection. 
To investigate the spatial distribution of 'low_RNA' cells in uninfected organoids and 
'highly_infected' cells in HSV-1 infected organoids, we integrated the spatial transcriptomic 
and the scRNA-seq datasets (Figure S4J-L). Following cluster label transfer from single-cell 
RNA-sequencing, we observed that in uninfected organoids, spots with high probabilities for 
'low_RNA' were mainly localized in the center of the section (Figure S4K, bottom row, left), 
indicating that 'low_RNA' cells were belonging to the organoid necrotic core. Conversely, 
already at 1 dpi higher scores for this type of cells were also found in the outer layers of the 
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organoids (Figure S4K, bottom row, middle), where also high levels of virus-derived GFP 
mRNA was localized (Figure S4K, top row, middle). In contrast, spots with high probabilities 
for neurons clustered in few, discrete spots (Figure S4K, bottom row). 
 
To corroborate the observation that spots in the spatial transcriptomics experiments bearing 
high levels of virus are abundant in highly infected cells, we plotted for each spot from the 1 
dpi infected organoids the GFP expression level against the probability for low RNA/highly 
infected (Figure S4L). As expected, high probability values for this type were observed mostly 
at spots with high levels of virus-derived RNA (Figure S4L, left), whereas high neuron 
probabilities were only present in spots with moderate levels of GFP-mRNA (Figure S4L, 
right). This confirms that increasing amounts of virus-derived RNA coincide with distribution 
of highly infected cells. 
  
Viral infection induces and shuts down molecular pathways in host cells  
To further characterize the cell-type specific transcriptional responses to HSV-1 infection, we 
performed a differential gene expression analysis between uninfected and 3 dpi organoids in 
each cell type (Methods, Figure 5A). Interestingly, the cell types with the highest amount of 
viral RNA (Figure 4E) did not show the strongest transcriptional response. Instead, numerous 
pathways were deregulated in epithelial and mesenchymal cells, which do not show high levels 
of viral RNA (Figure 4E). 
We could identify pathways that were globally dysregulated in all cell types such as TNF-α 
signaling via NF-κB, hypoxia, and the p53 pathway (Figure 5A, B and S5A).  
The enrichment of the p53 term was correlated with upregulation of genes such as JUN, FOS, 
IER3, ATF3, BTG2, HEXIM1, NDRG1, SAT1 and PLK2 (Figure S5B). A well-known tumor 
suppressor protein, p53 is activated by various stress signals. As viral infection evokes cellular 
stress, it is not surprising that infected cells activate the p53 pathway and also in our model we 
observed significant p53 activation in all cell types but, interestingly, not in neurons (Figure 
S5B).  
Furthermore, we observed upregulated metabolism-associated genes. For example, the 
mammalian target of rapamycin complex 1 (mTORC1) pathway, which was upregulated in 
progenitors, neurons, neuroepithelium and mesenchymal cells but downregulated in the 
progenitors 2 cluster. HSV-1, produces capped mRNAs which engage cellular ribosomes.  In 
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order to translate its own mRNAs stimulates cap-dependent translation by activating mTORC1 
to inhibit the translational repressor 4E-binding protein 1 (4E-BP1) (43,44). Activation of 
mTORC1 could therefore reflect an increase in the translation potential. 
Additionally, neuroepithelial cells showed upregulation of lipoprotein metabolism and 
signaling by G-protein coupled receptor (GPCR) pathways, but downregulation of cell-cycle 
and axon guidance related pathways (Figure 5C). On the other hand, intermediate progenitor 
and retinal ganglion cells showed downregulation of axon guidance and upregulation of pre-
mRNA processing related pathways (Figure 5C). Interestingly, these cell types contained a 
large amount of viral RNA, but their number was not affected upon infection (Figure 4C, F 
and S4K). These results indicate that HSV-1 replication causes deregulation of different 
cellular pathways globally but also in a cell-type specific manner. Furthermore, our data 
suggest that individual cell types cope differently with viral replication and high viral RNA 
content is not always a prerequisite for the strongest transcriptional response. 
 
HSV-1 infection induces hallmarks of neurodegeneration   
We investigated whether HSV-1 replication and inflammatory responses in infected organoids 
would lead to molecular changes associated with neurodegeneration. First, we assessed cell 
death by immunostaining with cleaved caspase-3 (CC3) antibody (Methods). We did not 
observe an increase in CC3 expression upon HSV-1 infection (Figure S6A). This is consistent 
with published reports from mouse models showing that herpes simplex viruses protect cells 
against apoptosis, via NF-κB activation and Casp3-dependent pathway (45). Next, we 
investigated early events which could lead to neuronal damage and synaptic dysfunction, 
preceding late pathological changes.    
One of the most profound phenotypes observed after HSV-1 infection was disruption of the 
tissue integrity in infected organoids. Therefore, we analyzed the expression of extracellular 
matrix (ECM) components (Figure 6A, S6B). We observed a strong (more than four-fold) 
reduction of decorin (DCN), biglycan (BGN), versican (VCAN) and aggrecan (ACAN), and a 
mild effect (log2 fold change > -2) on hyaluronan production (HAS1 and HAS2) in RNA-seq 
data after lytic organoid infection. We confirmed this finding by RT-qPCR analysis, using 
independent biological replicates for two different iPSC lines for collagen type 6A1 (COL6A1), 
desmin (DES) and BGN (Figure 6B). Furthermore, we validated a significant downregulation 
of collagen type 3A1 (COL3A1) by western blotting analysis (Figure 6C). On the other hand, 
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we found heparan sulphate modifying enzymes such as 3-O-sulfotransferase 2 and 6 
(HS3ST2/HS3ST6) among upregulated ECM transcripts (Figure 6A).  
Our analysis indicates that HSV-1 infection strongly affects expression of ECM components, 
which could trigger degeneration processes and could be associated with observed profound 
changes in organoid morphology and tissue integrity (Figure S6C).  
The second most prominent phenotype accompanying destruction of the organoid structure was 
strong downregulation of stathmin-2 (STMN2) transcript in both bulk and single-cell RNA-seq 
data (Figure 6D). Consistently, STMN2 expression was significantly downregulated in HSV-
1 infected organoids generated from both iPSC lines (Figure 6E, F and S6D, E). STMN2 
encodes a microtubule regulator, required for normal axonal outgrowth and regeneration. 
STMN2 downregulation has been associated with neurodegenerative diseases (46). It has been 
reported that STMN2 levels decrease following TAR DNA-binding protein 43 (TARDBP/ 
TDP43) knockdown or relocalization from the nucleus in human motor neurons (47) and a 
direct link between TDP43 loss in patients, pathology, and STMN2 down-regulation (25). 
Therefore, we compared TARDBP mRNA expression in bulk and single-cell RNA-seq data, 
but did not observe significant downregulation (Figure 6G). Since TARDBP is known to be 
regulated post-transcriptionally, we analyzed TDP43 localization and abundance in uninfected 
and infected organoids. We observed clear nuclear localization of TDP43 in uninfected 
organoids and, upon infection, relocalization to the cytoplasm upon HSV-1 infection (Figure 
6I for iPSC line-1 and S6F for iPSC line-2). Also, full-length protein level was significantly 
decreased (Figure 6H and S6G). Moreover, a known TARDP truncated 25 kDa neurotoxic C-
terminal isoform (26) could be observed only in infected organoids (Figure S6G).  
Besides splicing regulation, TARDBP/TDP43 is also involved in mRNA 3’ end formation 
(48,49). Therefore, we tested whether its deregulation could play a role in the observed changes 
in alternative polyadenylation (as shown in Figure 3). We analyzed the presence of published 
TARDBP/TDP43 binding sites (46,47,50) at the 3’ ends of mRNAs that we had annotated from 
our full-length transcript sequencing data (Methods). It has been previously shown that 
TARDBP/TDP43 binding close to polyadenylation sites often, but not always, represses their 
usage (50). Consistently, we observed a significant decrease in the usage of proximal PAS in 
isoforms which were bound by TARDBP/TDP43 compared to isoforms which were not (p-
value = 0.0012, Figure 6J). Given that viral infection affects the usage of proximal 3’ ends, 
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and at the same time it affects TARDBP/TDP43 expression and localization, we would expect 
a possible attenuation in the downregulation of proximal isoforms. The difference in the 
isoform usage change upon infection between TARDBP/TDP43 bound and unbound 3’ 
isoforms was mild and non-significant (Figure 6J). On the other hand, for those genes that are 
known to be regulated by TARDBP/TDP43 in the opposite way (enhancing usage of the 
proximal PAS or repressing that of distal ones (50)) we observed that the viral infection induced 
a strong shift in 3’ isoform usage, significantly larger than the rest of the genes (p-value = 
0.0013, Figure 6J). This is what would be expected knowing that TARDBP/TDP43 favors 
proximal isoform usage in these genes.  
Furthermore, in our data we observed a dysregulation of non-coding RNA BC200/BCYRN1, 
which localizes to dendrites where it contributes to the maintenance of long-term synaptic 
plasticity (24). Although the majority of dendritic transcripts such as MAP2 show 
downregulation upon HSV-1 infection, BC200 was strongly upregulated already at 1 dpi, and 
its expression correlated with expression of HSV-1 viral genes (Figure 6K and S4I). We also 
confirmed this finding in the bulk RNA-seq data (Figure S6H). 
  
Together, these results suggest that there are several molecular changes in HSV-1 infected 
organoids which could be linked to neurodegeneration and could contribute to later 
pathological changes.  
The Herpes simplex ICP27 mutant has weaker neurodegenerative potential  
To determine whether the observed changes related to neurodegeneration are directly 
dependent on HSV-1 replication, we compared wild-type (WT) HSV-1 with a ICP27 deletion 
mutant (ICP27 MUT). ICP27 is an essential protein for the expression of late genes as well as 
the synthesis of viral DNA (46). Because the ICP27 mutant is known to be less efficiently 
replicating in human cells (51,52), we compared organoids infected for two days with WT virus 
to these infected for four days with the mutant strain. This experimental setup allowed us to 
keep a similar expression level of viral proteins between conditions (Figure 7A). Because 
STMN2 level was strongly affected by the WT virus, we performed western blot and 
immunostaining analysis of STMN2 expression in both conditions, to determine impact of the 
mutant virus on its expression. We observed that STMN2 was less depleted in ICP27 MUT 
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when compared to WT and its protein expression anticorrelated with viral protein (ICP0) 
expression (Figure 7B, C). Also, the organoid integrity and proliferating progenitors were less 
affected by the mutant strain (Figure S7A). This suggests that the observed neurodegeneration 
related changes are directly related to viral replication and could be decreased (or perhaps even 
treated) by lowering the efficiency of viral replication as shown for HSV-1 ICP27 mutant.  
 
Discussion 
Although the course of HSV-1 infection has been studied, the molecular mechanisms of virus-
driven brain inflammation and neurodegeneration are elusive. This is arguably due to the 
absence of human model systems that are experimentally accessible and that capture the 
complexity of different cell types linked together in neural tissues. In this study, we 
demonstrate that human brain organoids, combined with a broad range of RNA, protein, and  
electrophysiological analyses tools, can fill this gap. Specifically, we show (a) how HSV-1 
“invades” neural tissue space, (b) how it differentially replicates in different cell types, (c) how 
it affects synapse functionality (impairing both spike rates but also spike coordination), (d) that 
it triggers the up-/down-regulation of specific human molecular pathways in a cell-type specific 
way, (e) that it targets certain molecular mechanisms such as adenylation site choice, poly(A) 
tail length, and antisense transcription to manipulate host-cell response, and (f) that it likely 
triggers the molecular onset of neurodegeneration (as we see the up-regulation/dysregulation 
of key markers of Alzheimer’s disease in infected organoids). We therefore believe that our 
results contribute to a much more detailed molecular and functional understanding of cell-type 
specific consequences of HSV-1 infection and establish human brain organoids as a powerful 
model system to advance this approach in the future. Of course, the brain organoids used in 
this study capture only a small part of the true complexity of human brains as they represent 
only fetal brains and lack immune cells and blood vessels. However, we did observe 
dysregulation of the interferon pathway (down-regulated in astroglia and mesenchymal cells) 
and the NF-κB pathway (up-regulated in most cell types and thus blocking apoptosis, favoring 
HSV-1 replication). Both pathways are crucial for the function of the innate immune system, 
thus indicating that our organoid-infection model may be used to study how HSV-1 escapes 
the innate immune response in a neuronal tissue. In any case, the organoid field makes rapid 
progress and we believe that future organoid models will capture more of human brain biology 
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(such as microglia) and thus, arguably, increasingly detailed and medically relevant aspects of 
HSV-1 infection. We believe that our study may serve as a reference point for this future 
research. Since organoids are genetically easily accessible and allow, as we demonstrate, to 
quantify cell-type specific effects of infection, perturbation studies may reveal new potential 
cell-type specific drug targets (or combinations thereof) to impact viral replication, or host-cell 
response, or possibly targets that modulate the onset of neurodegeneration. Moreover, 
organoids could serve as a model to screen for compounds, drugs, or modern vaccines, possibly 
in preclinical settings, that can prevent infection or treat the functional consequences of 
infection. 
We now discuss one of the most striking molecular mechanisms that we found to be involved 
in modulating viral-host-cell interactions: alteration of poly(A) tails of cellular messages and a 
striking switch in their usage of polyadenylation sites, as revealed by our full-length mRNA 
and poly(A) tail sequencing. We note that we are not aware of any other animal system in 
which such a strong switch of 3’ UTR isoform usage has been reported previously, and believe 
therefore that this effect is particularly important for understanding the impact of HSV-1 
infection on human cells. These tail alterations and 3’ UTR usage switches are highly likely to 
affect the expression, the localization and even the function of mRNAs and their resulting 
protein products. This is particularly obvious for the 3’ UTR usage switches as 3’ UTRs are 
key targets of (hundereds of) miRNAs and (thousands of) RNA binding proteins that alter 
localization, expression, turnover, and translation of the respective mRNA (53,54). Regarding 
poly-A-tails, the de-adenylation of mRNAs is coupled with translation (55) and it is known 
that more actively translated and more stable mRNAs tend to have shorter poly(A) tails at the 
steady state (56). We observed a general increase in tail length of host mRNAs, which could 
reflect their reduced translation and/or different transcription and turnover kinetics. The 
observed shift in poly(A) length seemed to be rather global and did not affect any specific gene 
categories. On the other hand, fewer transcripts had reduced tail length upon infection. These 
were enriched for genes involved in promoting HSV-1 infection such as CDK9 (57) and could 
represent a subset of mRNAs crucial for early viral replication. Besides observing changes in 
poly(A) tail length of mRNAs, we report vast changes in alternative polyadenylation. It was 
recently shown that the viral protein ICP27 affects 3’ end formation of host mRNAs by binding 
the cleavage and polyadenylation complex and suppressing its activity on termination sites 
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(58). The consequent transcriptional readthrough might lead to increased usage of distal 
polyadenylation sites, which we consistently observed upon infection. Interestingly, an 
opposite effect - a global shortening of 3’UTRs - was observed after vesicular stomatitis virus 
(VSV) infection in microphages (35), which suggest that effects on 3’ end formation are rather 
virus specific. Of note, the RNA binding protein TARDBP/TDP43, whose levels and 
localization are affected by viral infection, is known to be involved in 3’ end formation, for 
example by binding close to polyadenylation sites and repressing their usage. It follows that its 
mis-expression would lead to increased usage of bound polyadenylation sites, while at the same 
time transcriptional readthrough or other virally induced mechanisms decrease usage of 
proximal termination sites. On the other hand, TARDBP/TDP43 can also favor proximal 
isoform usage in certain genes (50). In these cases, we would expect a stronger shift towards 
distal polyadenylation sites upon viral infection, which was indeed reflected in our data. There 
is now an increasing body of evidence showing that a specific 3’ untranslated region isoform 
can contribute to pathology related phenotypes. As an example, the extended 3′ UTR of α-
synuclein isoform (aSynL isoform) has been previously shown to impact accumulation of α-
synuclein protein, and its relocalization from synaptic terminals to mitochondria, characteristic 
of Parkinson's disease pathology. Interestingly, we could also observe an expression of aSynL 
isoform exclusively in HSV-1 infected organoids, however due to low number of reads 
covering this region, this observation will require further investigation.   
 
We now discuss one of the perhaps most interesting questions, i.e., do we see indications that 
HSV-1 infection is possibly involved in triggering neurodegeneration?   
 
Progressive loss of neuronal structure and function can be driven by different cellular 
alterations. In our system we could observe several molecular changes which can be directly 
linked to neurodegeneration processes. Firstly, dysregulation of the extracellular matrix (ECM) 
genes and ECM disruption can lead to synaptic and neuronal loss, promoting the pathogenesis 
of neuropathological states (59) and neurodegeneration (59). Interestingly, we observed 
upregulation of ECM enzymes involved in 3-O-sulfation of heparan sulphate such as HS3ST2 
and HS3ST6 in infected organoids. 3-O-sulfation of heparan sulphate results not only in 
dramatic increase of susceptibility to viral infection (60), but also causes heparan sulphate 
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internalization, promoting abnormal phosphorylation of tau in Alzheimer's disease-related tau 
pathology (61).  
 Secondly, we observed specific molecular alterations linked to neurodegeneration: (a) 
downregulation of the microtubule regulator STMN2, that has been previously associated with 
neurodegenerative diseases (46), (b) TDP43 protein downregulation and/or relocalization from 
the nucleus, which is a hallmark of diseases associated with TARDBP/TDP43 proteinopathies 
such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Alzheimer's 
disease (AD) (25,49), (c) upregulation of the small noncoding RNA BC200, which was shown 
to be associated with AD and variety of tumors (24,62). The upregulation of BC200 during 
HSV-1 infection is most likely associated with widespread induction of antisense transcription. 
 
BC200 is selectively expressed in synaptodendritic neuronal compartments, where it is thought 
to modulates local protein synthesis and in normal aging, it is reduced by > 60% between the 
ages of 49 and 86. In contrast, in AD brains BC200 RNA was significantly dysregulated in the 
brain areas that are involved in the disease (24). However due to contradictory data in the 
context of AD (63), further investigation will be necessary to elucidate the expression and 
function of this interesting noncoding RNAs in diseased brains.  
 
Finally, our data indicate that HSV-1 infection very rapidly alters neuronal tissue functionality 
as indicated by decreased firing rates and loss of coordinated neuronal activity. Extensive 
studies from human AD patients and animal models suggest that destabilization of spontaneous 
neuronal activity in cortical and hippocampal circuits is a typical feature of AD 
pathophysiology and can be detected already at very early stages of the disease (64–66). We 
suggest that it is crucial for future studies to combine highly resolved electrophysiological data 
with spatial transcriptomics, in order to define the transcriptome changes accompanying 
functional defects and their association with neurodegenerative processes. 
Taken together, our data uncover several molecular and functional defects of neuronal tissue, 
directly or indirectly caused by HSV-1 infection. We suggest that further studies should focus 
on elucidating the exact chain of molecular events (including earlier events than covered in our 
approach) leading to the observed signatures of neurodegeneration, and how these may be 
tackled with antiviral or more targeted therapies. 
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Figure 1. Human brain organoids as an experimental model to study mechanisms of HSV-
1 lytic infection in complex brain-like tissue. A. Schematic overview of cerebral organoids 
generation using iPSCs. Lower panel: representative images of organoids at different 
developmental stages. B. Exemplary immunohistochemistry of 60 days old uninfected brain 
organoid showing location of neuronal progenitors (SOX2-cyan) and neurons (TUJ1-magenta). 
Scale bar - 500 µm Small panels display higher magnification of representative 
immunohistochemistry for progenitors (SOX2-cyan), intermediate progenitors (EOMES-
cyan), neurons (MAP2, RELN, LHX2-cyan), deeper layer cortical neurons (TBR1-cyan) and 
nuclei (DAPI-blue). Scale bar - 100 µm. C. UMAP analysis of cells colored by cell type in 
uninfected 60 days old brain organoid. D. Representative images from the spatial 
transcriptomics analysis of 60 days old organoids for markers: DCX - neurons, SYN1 – 
synapses, TTR - choroid plexus, MKI67 - proliferating radial glia (RG). Colors indicate log2 
mRNA expression levels. E. Spatial transcriptomics analysis of HSV-1 GFP expression in 
uninfected (CTR) as well as 1 and 3 days post infection (dpi). Colors indicate log2 GFP mRNA 
expression. 
  
Figure 2. Infection of brain organoids captures known facts about HSV-1 infection: 
impaired synaptic activity and activation of antisense transcription. A. Gene expression in 
uninfected (CTR) and 3 days infected (+HSV-1) organoids. Yellow: transcripts related to 
chemical synaptic transmission. Large data points: statistically significantly de-regulated 
genes. Blue: other transcripts. B. Exemplary immunohistochemistry for synaptic 
(SYN1 – white, magenta) neuronal, nuclei (DAPI – white, blue) and HSV-1 (GFP - white) in 
uninfected and infected organoids. Scale bar - 100 µm. C. Representative western blots of 
synaptic proteins (ARC, HOMER1, SYN1) and a housekeeping protein (GAPDH) of 
uninfected (CTR) and infected (+HSV-1) organoids. D. Box plots showing log2 fold changes 
of sense annotated genes (grey) and antisense transcripts 3 and 6 days post infection (dpi). E. 
Examples of antisense transcripts: NFIC (antisense internal) and POLR3Eas (antisense 
divergent). Coverage profiles of total RNA-sequencing data from 60 days old cerebral 
organoids. Sense genes in blue (orange) oriented left to right (right to left). Transcript 
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annotation in dark blue.  F. Heatmap plots of the number of spikes captured by the most active 
electrodes of each replicate (n=3) in uninfected (CTR, green) and HSV-1-GFP infected (+HSV-
1, red) organoid over 48 hours. G. Representative image of CalBryte590 AM (green) loaded, 
showing GFP virus expression (grey) at 48 hours post infection (hpi). Scale bar – 100 μm (left 
panel). Color-coded images illustrating spike frequency (right panel). H. Spike detection plot 
for all regions of interest (ROI) in uninfected (CTR – upper panel) and HSV-1-GFP infected 
(+HSV-1 – lower panel) organoids.  
 
Figure 3. HSV-1 causes genome-wide lengthening of human poly(A) tails and abundant 
changes in polyadenylation site usage. A. Difference of median poly(A) tail length per gene 
in infected minus uninfected (in nucleotides), plotted against log2 expression level in 
uninfected (in read counts). Fill color represents the same as the y-axis to better visualize the 
changes in tail length. Blue circles mark genes with different median length of at least 25 nt 
and p-value < 0.05 (n = 1, three merged replicates, see methods). B. An example of shift in TTS 
usage, after HSV-1 infection for calmodulin 1 (CALM1). The FLAM-seq reads from uninfected 
organoids are depicted in green, and from infected organoids in red. Poly(A) tails are appended 
to the 3’ end of reads and visualized as stretches of mismatches in red. Gencode annotation for 
the longest isoform is shown above in black. C. Isoform usage in infected (red) and uninfected 
(green), sorted by 3’ end isoform index, from proximal to distal. A scheme of isoform index 
annotation is provided below. The change in isoform usage between non-infected and infected 
was tested with Wilcoxon rank sum test (for proximal isoforms in CTR vs HSV-1, p-value = 
0.0098). The difference in the change in proximal isoform usage between high readthrough 
genes and other genes was tested with Wilcoxon rank sum test (p-value = 0.2548).  
Figure 4. Cell-type specificity of virus infection susceptibility. A. and B. UMAP embedding 
of cells from uninfected organoids and 3 days post infection (dpi). In (A), cells are colored by 
their respective type. In (B), cells were colored by the relative density (infected vs. uninfected) 
of the area in which they are located, with red and blue indicating increased and decreased 
density upon infection, respectively. Example: cells in the bottom left are in an area with 
increased number of cells from infected organoids. C. Proportion of cell types in uninfected or 
infected organoids (lower panel), and p-values for testing differences (upper panel). Dashed 
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line indicates p-value cutoff of 0.001. D Representative immunohistochemistry for mitotic 
marker (pVIM – white) and merged images for mitotic marker (pVIM - cyan), HSV-1 
(GFP - white), nuclei (DAPI - blue) in uninfected (CTR) and 3 dpi infected (+HSV-1) 
organoids. Scale bar - 100 µm. E. Box plot showing log10 transformed percentages of viral 
RNA per cell (viral load). Lower and upper hinges correspond to the first and third quartiles. 
Whiskers extend to a maximum of 1.5 times the distance between the first and third quartile. 
Outliers beyond are marked by single dots. Notches extend 1.58 * interquartile range divided 
by the square root of number of cells. F. Cells corresponding from the indicated cell types were 
sorted by amount of viral RNA, grouped into bins of 20 cells, and normalized expression gene 
expression values calculated per bin. Plotted are the expression values of the GFP mRNA 
originating from the viral genome against US1 (top left), UL51 (top right), and LAT (bottom 
right).  
Figure 5. Viral infection induces and shuts down molecular pathways in host cells. A. 
Gene set enrichment analysis for each cell type, on differential expression between infected (3 
days post infection (dpi)) and uninfected organoids. Color indicates normalized enrichment 
score (NES) values and dot size showing -log10 (FDR) from statistically significant pathways 
(FDR < 0.05). B. Violin plot showing log2 fold changes of TNF-α signaling for each cell type. 
Red dots: genes with positive log2 fold changes. C. Violin plot showing log2 fold changes for 
statistically significant genes per pathway for each cell type (neuroepithelium, retinal ganglion, 
intermediate progenitors). Red (blue) dots: genes with positive (negative) log2 fold changes. 
Figure 6. Hallmarks of neurodegeneration caused by HSV-1. A. Gene expression 
(transcripts per million - TPM) changes in uninfected (CTR) versus infected (+HSV-1) 
organoids, transcripts related to extracellular matrix (GO:0031012) in yellow, significantly 
deregulated ones show as large points, red boxes depict genes validated by qPCR. Blue data 
points indicate other transcripts. B. Quantitative real-time PCR analysis of COL6A3, BGN and 
DES transcript expression in organoids derived from two iPSC lines, 3 days post infection (3 
dpi). Values are given as SEM, n = 6 biological replicates from two iPSC lines. Statistical 
analysis was performed by Wilcoxon rank sum test. *indicates statistically significant 
differences between uninfected and infected organoids (*p-value ≤ 0.05). C. Representative 
western blots and relative protein expression semi-quantified by densitometry analysis of 
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collagen type 3A1 (COL3A1) of uninfected (CTR) and 3 dpi infected (+HSV-1) organoids, 
normalized to GAPDH expression. D. Single-cell mRNA expression of stathmin-2 (STMN2). 
Each dot represents a single cell. Statistically significant gene expression is observed only if a 
violin-shaped fitting area can be calculated. E. Representative western blots and relative 
protein expression semi-quantified by densitometry analysis of STMN2 of uninfected (CTR) 
and 3 dpi infected (+HSV-1) organoids, normalized to GAPDH expression. F. Exemplary 
immunohistochemistry for neurons (STMN2 – white/cyan), nuclei (DAPI - white/blue) and 
HSV-1 (GFP - white) in uninfected (CTR) and 3 dpi infected organoids (+HSV-1). Scale bar - 
100 µm. G. Single-cell expression of TAR DNA-binding protein 43 (TARDBP). Each dot 
represents a single cell. H. Representative western blots and relative protein expression semi-
quantified by densitometry analysis of TDP43 of uninfected (CTR) and 3 dpi infected (+HSV-
1) organoids, normalized to GAPDH expression. I. Exemplary immunohistochemistry for 
nuclear protein (TDP43-red), nuclei (DAPI-blue) and HSV-1 (GFP-white) in uninfected (CTR) 
and 3 dpi infected organoids (+HSV-1). Scale bar - 100 µm. Values are given as mean ± SEM. 
n = 5-6. Statistical analysis was performed by unpaired student’s t-test for direct comparisons 
of two independent groups. *indicates statistically significant differences between uninfected 
and infected organoids (*p-value ≤ 0.05; ****p-value ≤ 0.0001) (two independent 
experiments). J. Proximal isoform usage (y axis) for genes with alternative polyadenylation. 
Of those, genes with proximal isoform not bound by TDP43 (TDP43 unbound), genes with 
proximal isoform bound by TDP43 (TDP43 bound), and genes where usage of proximal 
isoform was reported to be enhanced by TDP43 or distal isoform to be repressed by TDP43 in 
(50) (“Proximal favored by TDP-43”). Green dots and boxes represent non-infected samples, 
red infected samples. The different usage of proximal isoforms in uninfected organoid samples 
between TDP43-bound and unbound isoforms was tested with Wilcoxon rank sum test, p-value 
= 0.0012. When comparing the difference in proximal isoform usage of infected and non-
infected samples between all the gene categories in x, only the last category differed 
significantly from the set of all genes with alternative polyadenylation (Wilcoxon rank sum test 
p-value = 0.0013). K. Representative images from the spatial transcriptomics analysis of 60 
days old organoids for dendritic transcripts noncoding BC200/BCYRN1 and MAP2. The colors 
indicate log2 expression. 
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Figure 7. Herpes simplex ICP27 mutant exhibit weaker neurodegenerative potential. A. 
Representative western blots of stathmin-2 (STMN2), housekeeping protein (GAPDH) and 
viral ICP0 protein of uninfected (CTR) and organoids infected using HSV-1 wild-type (WT) 
virus (2 dpi), and ICP27 mutant (MUT) virus (4 dpi). B. Relative protein expression semi-
quantified by densitometry analysis of STMN2 of uninfected (CTR), HSV-1 WT and HSV-1 
ICP27MUT infected organoids, normalized to GAPDH expression. Values are given as mean 
± SEM. n = 3. Statistical analysis was performed by unpaired student’s t-test for direct 
comparisons of two independent groups. *indicates statistically significant differences between 
uninfected and infected organoids (**p-value ≤ 0.01). C. Exemplary immunohistochemistry 
for STMN2 (red), DAPI (blue) and viral ICP0 (white) in the uninfected (CTR) and organoids 




The human iPSC lines iPSC-1 XMO01 (67) and iPSC-2 (A18945, Thermo Fisher Scientific) 
were cultured  in standard conditions (37°C, 4% CO2, and 100% humidity), in E8 Flex medium 
(Thermo Fisher Scientific). 
 
Generation of cerebral organoids 
We generated iPSC-derived cerebral organoids according to a protocol previously described 
with some modifications (27,28). Shortly, after dissociation into single-cell suspension with 
accutase, we seeded 6,000 cells per one well of 96-well plates in 100 µl of embryoid body 
(containing: DMEM/F12, 20% Knockout replacement serum, 1x Glutamax, 1x MEM-NEAA, 
2% ESC FBS, 50µM ROCK Inhibitor, 10 µM bFGF) medium. After 4 days, we replaced the 
medium with EB medium without bFGF and ROCK inhibitor. On day 6, we replaced the 
medium with a neural induction medium (NIM:  DMEM/F12, 1x N2 supplement, 1x Glutamax, 
1x MEM-NEAA, 10µg/ml heparin solution). At day 7-9, we embedded the formed organoids 
into Matrigel (Corning, 356234) and kept them in NIM for two days, and in organoid 
differentiation medium containing 1:1 DMEM/F12: Neurobasal, 1xN2 supplement, 1x B27- 
vitamin A supplement, insulin, 2-ME solution, Glutamax, MEM-NEAA, CHIR99021 for 
another four days. Next, we transferred the organoids to ultra-low attachment 6-well plates and 
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cultured them on an orbital shaker (80 rpm) in organoid maturation medium containing 1:1 
DMEM/F12: Neurobasal, N2 supplement, B27+ vitamin A supplement, insulin, 2-ME 
solution, Glutamax supplement, MEM-NEAA, Sodium Bicarbonate, Vitamin C solution, 
chemically defined lipid concentrate, BDNF, GDNF, cAMP, 1% Matrigel.  
 
Viral infections  
The following HSV-1 strains were employed in this study: strain 17 containing GFP under an 
MCMV promoter (68) KOS (VR-1493; ATCC), and a KOS-based ICP27 knockout virus (52). 
Around 5-10 organoids cultured in 6-well plates were infected with 75,000 PFU of HSV-1/ per 
organoid (corresponding to an MOI of 1 as calculated from the estimated number of cells at 
the surface of the organoids), and 24 h after the medium was replaced with fresh organoid 
maturation medium and organoids were cultured for an additional 3 or 6 days (3 dpi/6 dpi). 
The control organoids were culture in parallel in the same conditions, but without viral 
infection.  
 
 PCR analyses and Nanostring 
We performed gene expression analysis by quantitative real-time RT-PCR (qPCR) using 
SYBR Green PCR Master Mix (Thermo Fisher Scientifics, #4309155) and the ViiA™ 7 Real-
Time PCR System (Applied Biosystems). For each target gene, we measured cDNA samples 
and negative controls in triplicates using ABI PRISM™ 384-well Clear Optical Reaction Plate 
(Applied Biosystems/ Thermo Fisher Scientifics, #4309849). We calculated the relative 
transcript levels of each gene based on the 2− ΔΔCT method or as the percentage of 
housekeeping gene expression. All primer sequences are reported in Table S3. We performed 
Nanostring-based differential expression analyses of mRNA expression using a custom-
designed 72-plex Nanostring nCounterTM probes panel. The mRNA transcript quantification 
analysis, including sample preparation protocol, hybridization, and detection was performed 
according to manufacturer’s recommendations. 
 
Immunostaining of brain organoids 
For immunostaining organoids were washed three times with PBS and fixed tissue in 4% 
paraformaldehyde for 20 to 60 min (depending on the organoid size) at 4 °C, washed with PBS 
three times 10 min. The tissue was incubated in 40% sucrose (in PBS) till it sunk (overnight) 
and embedded in 13%/10% gelatin/sucrose. Frozen blocks were stored at -80 °C, prior 
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cryosection. 10-14 μm sections were prepared using cryostat (Leica). Sections were incubated 
with warm PBS 10-15 min, to remove the embedding medium and next fixed for additional 10 
min with 4% PFA, washed three times with PBS and blocked and permeabilized in 0.25% 
Triton-X, 5% normal goat serum in PBS for 1 h. Sections were incubated with primary 
antibodies (Table S3) in 0.1% Triton-X, 5% normal goat serum overnight, and the washed three 
times 10 min with PBST (0.1% Triton X-100) and incubated with secondary antibodies at RT 
for 2 h, stain with DAPI (final 1 µg/ml) for 10 min and washed three times with PBST. The 
images were acquired using a Keyence BZ-X710 (Osaka, Japan) microscope. 
 
Western Blotting 
Organoids were lysed in RIPA buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris, 1% NP-40, 
0.5% sodium deoxycholate and 0.1% SDS) in the presence of protease and phosphatase 
inhibitors. Subsequently, the samples were incubated on ice for 30 minutes and centrifuged at 
14,000 x g for 20 minutes at 4 °C. The total protein concentrations were determined using the 
Pierce™ BCA assay (Thermo Fisher Scientific, #23225). Samples (10-20 µg) were boiled in 
standard SDS-PAGE sample buffer supplemented with 100 mM DTT, boiled at 95 °C and 
resolved in a 10–12% SDS–PAGE. Proteins were transferred onto Transblot Turbo Midi PVDF 
membranes (Bio-Rad, #1704157). The membrane was blocked with Tris-buffered saline 
containing 0.1% Tween-20 (TBST, Sigma-Aldrich) supplemented with 5% skimmed milk for 
1 h at room temperature. Subsequently, the membranes were incubated with the primary 
antibodies (Table S3) diluted in TBST with skimmed milk at 4 °C overnight. After washing in 
TBST, the membranes were incubated with anti-rabbit or anti-mouse horseradish peroxidase-
conjugated secondary antibody (Cell Signaling, Frankfurt/Main, Germany) for 1 h at room 
temperature. Blots were then developed with AmershamTM ECLTM select reagent (Cytiva, 
RPN3243) and visualized by Fusion FX (Vilber, Collégien, France).  
 
RNA-sequencing 
For the total RNA sequencing we used 100 ng of total RNA, where rRNA was depleted using 
RNase H-based protocol. We mixed total RNA with 1 μg of a DNA oligonucleotide pool 
comprising 50-nt long oligonucleotide mix covering the reverse complement of the entire 
length of each human rRNA (28S rRNA, 18S rRNA, 16S rRNA, 5.8S rRNA, 5S rRNA, 12S 
rRNA), incubated with 1U of RNase H (Hybridase Thermostable RNase H, Epicentre), purified 
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using RNA Cleanup XP beads (Agencourt), DNase treated using TURBO DNase rigorous 
treatment protocol (Thermo Fisher Scientific), and purified again with RNA Cleanup XP beads. 
We fragmented the rRNA-depleted RNA samples and processed them into strand-specific 
cDNA libraries using TruSeq Stranded Total LT Sample Prep Kit (Illumina) and then 
sequenced them on NextSeq 500, High Output Kit, 2 x 76 cycles. We performed differential 
gene expression analysis using the DESeq2 (version 1.20.00) R package. 
  
RNA-seq data analysis 
RNA-seq reads were mapped to the reference containing human GRCh38 and HSV-1:GFP 
genomes using STAR version 2.7.1a (69).  Default settings were used, with the exception of ‘-
-outFilterMismatchNoverLmax 0.05’. Reads were counted using htseq-count (version 0.9.1 
(70)) with GENCODE v27 genome annotation reference (71). Principal component analysis 
was done on raw read counts after performing variance stabilizing transformation using the vst 
function from the DESeq2 package version 1.26.0 (72).  
Differential gene expression analysis 
Differential gene expression analysis was done using DESeq2 (version 1.26.0), using default 
options, and multi-factor design that measures the effect of infection while accounting for 
differences between cell lines (design = ~ cell_line + day_post_infection). Significance 
threshold was set to adjusted P-value of 0.05 and log2-fold-change of 1. Gene ontology 
enrichment analysis was done using the gprofiler2 R package (73). All genes expressed in our 
system were used as background. GO terms with adjusted p-value lower than 0.05 were 
considered significantly enriched. 
Antisense transcription analysis 
Antisense transcribed regions were identified and defined from STAR-aligned reads using the 
running sum algorithm described (31). Overlapping antisense transcripts from different RNA-
seq libraries were collapsed together. All putative antisense transcripts with an annotated 
upstream sense gene within 1 kb were discarded as potential readthroughs, and those with a 
downstream sense gene within 10 kb were discarded as potential transcripts from an upstream 
TSS. We extended the GENCODE v27 genome annotation reference with detected antisense 
transcripts and counted the mapping reads using htseq-count 0.9.1, as described earlier.  
 
FLAM-seq library preparation and data analysis 
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FLAM-seq libraries were prepared as described (23), starting with 2 micrograms of total RNA 
for three replicates of non-infected and three replicates of infected (3 dpi) 60 days-old 
organoids. A detailed version of the protocol can be found on protocolexchange 
(10.21203/rs.2.10045/v1). The only modifications in the protocol were the incubation of the 
RT reaction for 90 minutes at 42 °C, and the PCR amplification of cDNA performed for 23 
cycles with an extension time of 5 minutes per cycle. Libraries were then submitted to the 
BIMSB Genomics core facility for PacBio amplicon template preparation (SMRTbell Express 
Template Prep Kit 2.0, 100-938-900) and sequencing on the PacBio Sequel (Sequel Binding 
and Internal Ctrl Kit 3.0, 101-626-600). Sequencing was performed on diffusion mode on two 
SMRTcells for each sample and then raw data were preprocessed with SMRTlink 
v8.0.0.80.529 for CCS generation with a minimum number of 3 passes and a minimum 
predicted accuracy of 0.99. The CCS reads were then used as input to the FLAM-seq analysis 
pipeline (23) that outputs gene assignment and poly(A) tail length and sequence for each read. 
These data, deposited along with the CCS reads on GEO (74) were used for the plots showing 
read counts and poly(A) tail lengths in Figures 3, Figure S3 and Table S1. As a reference 
genome and genome annotation, we used GRCh38 with the addition of the HSV-1 genome 
(75) and Gencode v27 respectively. 
Statistical testing of differences in poly(A) tail length between non-infected and infected 
samples was performed on the merged 3 replicates per condition with the same method and 
code as described in detail (23). Briefly, the error of tail length measurement for each transcript 
was interpolated by fitting a linear model to the standard deviations observed using synthetic 
spike-ins of known lengths. For any given sequenced tail, a new length was sampled from a 
normal distribution given the aforementioned expected standard deviation, and a p-value was 
then computed by comparing the measured median tail length with the median tail length of 
the distribution sampled 1000 times. An additional cutoff at 25 nt was set to increase 
specificity.  
Gene ontology terms enrichment analysis was performed with Gorilla (76), by using genes with 
significant poly(A) tail length difference between non-infected and infected samples as input 
(separately for genes with longer or shorter tails in one condition versus the other), and all 
detected genes in the FLAM-seq data as background. The GO terms “Positive Regulation of 
Viral Transcription” and “Regulation of Viral Transcritption”, driven by the genes GTF21, 
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DHX9, CDK9, POLR2K, NELFCD, NUCKS1, NELFE and CCL5, were the only ones found 
enriched with an adjusted p-value lower than 0.05. 
Three prime end annotation was performed as in (23) on the merged replicates for infected and 
uninfected organoids by peak detection on aligned reads 3’ end positions with the Python 
peakutils module (https://bitbucket.org/lucashnegri/peakutils), by setting a minimum distance 
of 30 nt between the peaks, keeping only genes with at least 5 read counts, and keeping only 
peaks supported by at least 2 reads . Reads from the two conditions (infected and uninfected) 
were then assigned to the detected peaks by simply ascribing the 3’ end position of the read 
alignment to the closest peak within a 15 nt distance. An isoform index was computed by 
sorting isoforms for each gene by coordinate: the most 5’ isoform on the gene strand was 
annotated with an index of 1, which increases distally until the last isoform for that given gene 
is detected. For the two conditions, isoform usage was computed as the fraction of read counts 
for a given isoform on the read counts for a given gene. To increase accuracy in isoform usage 
estimates, only genes with at least 10 read counts were retained when comparing usage between 
conditions (Table S2).  
High readthrough genes shown in Figure 3D were annotated as those genes having more than 
25% readthrough at 8 hours post infection (WT virus) in (38). 
TARDBP/TDP43 binding for each isoform was obtained by downloading iCLIP data from 
imaps.genialis.com. Bed files of CLIP sites from the entries 72094, 72102, 69197, 65156, 
69164, 69172, 69148, 69124, 69132, 69098, 69106, 69114, 69090, 69074, 69082, obtained 
from a variety of human cell lines and human samples, were merged and intersected with 
bedtools to get CLIP sites overlapping a sequence of 40 nt around FLAM-seq-annotated 3’ 
ends. Functional annotation of TARDBP/TDP43 -regulated isoforms was retrieved from Rot et 
al. (2017) where we collected the list of genes in which TARDBP/TDP43 either significantly 
promoted proximal isoform usage or inhibited distal isoform usage. 
Statistical testing for the difference in distributions of tail lengths and isoform usage was 
performed with the R implementation of the Wilcoxon-Mann-Whitney test. This was applied 
to compare proximal (isoform index = 1) and distal (isoform index > 1) isoform usage in non-
infected and infected organoids, as well as to compare the difference in proximal isoform usage 
between uninfected and infected samples in genes with high readthrough versus the rest of the 
genes, and in isoforms stratified by TARDBP/TDP43 binding or regulation. 
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The FLAM-seq reads and poly(A) tail visualization were produced by generating a track hub 
on the BIMSB local copy of the UCSC genome browser. Reads alignments (bam files) resulting 
from the FLAManalysis pipeline were appended with the tail sequence trimmed by the 
FLAManalysis pipeline and are therefore visible on the genome browser as a stretch of 
mismatches in red. 
 
Single cell RNA-seq 
Methanol-fixed cells were centrifuged at 3000–5000 × g for 5 min, rehydrated in 1 ml 
PBS + 0.01% BSA supplemented with RNAse inhibitors (1 unit/μl RiboLock, ThermoFisher), 
pelleted and resuspended again in 0.5 ml PBS + 0.01% BSA in the presence of RNAse 
inhibitors. Cells were manually counted by means of a hemocytometer and diluted to a 
suspension of typically ~300 cells/μl in PBS + 0.01% BSA. Cells were encapsulated together 
with barcoded microparticles (Macosko- 2011-10 (V+), ChemGenes Corp. Wilmington, MA, 
USA) using the Dolomite Bio Nadia instrument, using the standard manufacturer’s dropseq-
based (Macosko et al. 2015) scRNA-seq protocol.  
Droplets were broken immediately after collection and cDNA libraries generated as previously 
described (https://doi.org/10.1016/ j.isci.2021.102151). First strand cDNA was amplified by 
equally distributing beads from one run to 24 Smart PCR reactions (50 μl volume; 4 + 9 to 11 
cycles). 20 μl fractions of each PCR reaction were pooled (total = 480 μl), then double-purified 
with 0.6 x volumes of AMPure XP beads (Beckman Coulter). Amplified cDNA libraries were 
assessed and quantified on a BioAnalyzer High Sensitivity Chip (Agilent) and the Qubit 
dsDNA HS Assay system (ThermoFisher). 600 pg of each cDNA library was fragmented, 
amplified (13 cycles) and indexed for sequencing with the Nextera XT v2 DNA sample 
preparation kit (Illumina) using custom primers enabling 3’-targeted amplification. The 
libraries were purified with AMPure XP Beads, quantified and sequenced on Illumina 
NextSeq500 sequencers (library concentration 1.8 pM; NextSeq 500/550 High Output v2 kit 
(75 cycles) in paired-end mode; read 1 = 20 bp using the custom primer Read1CustSeqB (39) 
read 2 = 64 bp). 
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is 
The copyright holder for this preprintthis version posted March 7, 2021. ; https://doi.org/10.1101/2021.03.05.434122doi: bioRxiv preprint 
31 
 Single-cell RNA-seq data analysis 
Quality control and data pre-processing 
Single-cell gene read count tables were generated using the PiGx-scRNA-seq pipeline 
(https://doi.org/10.1093/gigascience/giy123) version 1.1.4. Data was analyzed in R (v3.6) 
using Seurat (v3). Cells with less than 500 detected genes were filtered out, gene expression 
was normalized using the SCTransform workflow and the different samples (control, 3d pi, 6 
dpi) were then integrated using a mutual nearest neighbor approach as illustrated on the Seurat 
website (77). Dimensionality reduction was performed using PCA and we selected 30 PCs 
based on Elbow plot. The FindClusters function which implements shared nearest neighbor 
(SNN) modularity optimization-based clustering algorithm was applied with a resolution of 1.5 
and identified in 45 initial clusters for the entire dataset, and 21 for only ctrl samples. The 
UMAP algorithm was used to create two-dimensional projections to visualize the data. 
For identifying the markers for each cluster, the “FindAllMarkers” function with default 
parameters was used, identifying negative and positive markers for that cluster. To label 
clusters, we performed a comprehensive manual annotation of the clusters. 
Local density plot 
The relative density between uninfected and HSV infected organoids on UMAP was measured 
using 2D kernel density estimation (MASS v.7.3-53) by each experiment (78). log2 ratio 
between estimated density was projected on UMAP. 
Cell proportion 
Differences in cell type proportions were analyzed using mixed-effects linear models (lme4 
v.1.1-23) using a binomial model with cell type as fixed effect and replicates as random effect 
(73) p-value less than 0.001 was considered statistical significant. 
 
Differential gene expression and gene set enrichment analysis  
In order to identify differentially regulated genes among experiments, using Wilcoxon rank 
sum test by scTransform normalized counts was utilized. The adjusted p-value was calculated 
using Bonferroni Correction for multiple testing correction. 
To identify enriched pathways associated with HSV infection, GSEA using the fgsea (v1.10.1) 
was performed with 10,000 permutation. Ranking metric was done by logFC from Differential 
expression analysis. Two databases (REACTOME, HALLMARK pathway from the MsigDB) 
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were used as reference pathways. Only pathways with with more than 3 statistical significant 
reference genes, FDR < 0.05 were considered as significantly enriched.  
 
Tissue processing and Visium data generation 
Brain organoid samples, frozen in isopentane and embedded in OCT (TissueTek Sakura) and 
cryosectioned at −12 °C (Thermo Cryostar). Sections were placed on chilled Visium Spatial 
Gene Expression Slides (2000233, 10X Genomics). Tissue sections were then fixed in chilled 
methanol and stained according to the Visium Spatial Gene Expression User Guide (CG000239 
Rev A, 10X Genomics).   
Libraries were prepared according to the Visium Spatial Gene Expression User Guide 
(CG000239, https://assets.ctfassets.net/an68im79xiti/3pyXucRaiKWcscXy3cmRHL/a1ba41c
77cbf60366202805ead8f64d7/CG000239_VisiumSpatialGeneExpression_UserGuide_Rev_A
.pdf). Libraries were sequenced on a NovaSeq 6000 System (Illumina) using a NovaSeq S4 
Reagent Kit (200 cycles, 20027466, Illumina), at a sequencing depth of approximately 250-
400M read-pairs per sample. Sequencing of 10 µm organoid slices (four organoids/condition) 
yielded, for uninfected organoids, on average 8,000 unique molecular identifiers (UMIs), 
which quantified ~3,700 genes per spot. 
Label transfer from scRNA to spatial transcriptomic datasets 
We transferred labels from each of the clusters identified in the scRNAseq dataset to each spot 
in the spatial transcriptomic dataset using Seurat V3 (ref: Comprehensive Integration of Single-
Cell Data (77). Briefly, we used the SelectIntegrationFeatures with default parameters to 
identify the gene to use during the label transfer process and the FindTransferAnchors function 
(parameters:  normalization.method = "SCT",  reference.assay = 'SCT', query.assay = 'SCT', 
reduction = 'cca', dims = 1:30) to find the set of anchors between the single cell and the query 
spatial transcriptomic datasets. We then used the TransferData function (parameters: 
prediction.assay = TRUE, weight.reduction = 'cca', dims = 1:30) to obtain the prediction scores 
of each spatial transcriptomic spot for each of the single cell cluster. 
Multi-electrode array (MEA) recording  
Spontaneous extracellular field potential in uninfected and infected 60 days old organoids 
generated from iPSC line-2 were acquired in 6-well MEA plates with 64 poly-3,4-
ethylendioxythiophen (PEDOT) electrodes (Axion Biosystems, Atlanta, GA, USA). Each well 
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was previously coated with 100 μg/mL poly-D-lysine. In the following, 60 days old organoids 
were placed in the middle of each well. Subsequently, GeltrexTM was added on top of the 
organoid and placed for 30 min in the incubator to spatially fix the organoid. Afterwards, 
BrainPhysTM media supplemented with N2 supplement, B27+ vitamin A supplement, 20 ng/ml 
BDNF, 20 ng/ml GDNF, 0.5 mM dibutyryl cyclic-AMP and 200 nM ascorbic acid was added 
to the wells. Two days after organoid placement, recording was performed using a Maestro 
MEA system and AxIS Software Spontaneous Neural Configuration (Axion Biosystems). 
Spikes were detected with AxIS software using an adaptive threshold crossing set to 6 times 
the standard deviation of the estimated noise for each electrode (channel). The plate was first 
allowed to rest for three minutes in the Maestro device, and then 5 minutes of data were 
recorded. For the MEA analysis, the electrodes that detected at least 5 spikes/min were 
classified as active electrodes using Axion Biosystems’ Neural Metrics Tool. One hour after 
recording, three of six organoids were infected with 75,000 PFU of HSV-1 GFP/ per organoid 
and recordings were performed every hour for 48 h after 1 h of infection. We included in the 
analysis only the electrodes that were classified as active electrodes  at the time 1 h before 
infection. In every well, the ‘timepoint median’ was obtained by computing the median value 
of the number of spikes across active electrodes. For the heatmap in Figure 2D, we ranked 
each electrode in a single well by the total number of spikes measured and selected the four 
electrodes with the highest total number of spikes. In order to have a dynamic range between 
0 and 1, the number of spikes was max-normalized. Briefly, the number of spikes measured 
across all electrodes and timepoints in a single sample was divided by the maximum number 




For calcium imaging experiments, organoids were plated in 35 mm glass bottom imaging dish 
coated with poly-D-lysine and GeltrexTM. Two days after plating, organoids were loaded with 
5μM CalBryte590 AM (AAT Bioquest) and 0.02% Pluronic acid in organoid maturation media 
for 30 min at 37 °C. Imaging was performed in a Dragonfly spinning disk confocal microscope 
(Andor, Oxford Instruments) at a frequency of 5 Hz for 5 min. The resulting images were then 
background subtracted and the relative changes in intensity over time were computed. Activity-
based segmentation was performed as in Junek at al. 2009 (79). Spike detection was performed 
on the intensity traces from each ROI to calculate AP firing frequency.  
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